← All trials
NCT04756830
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 19, 2021
- Primary completion
- Sep 30, 2021
- Completion date
- Jun 30, 2023
- First posted
- Feb 16, 2021
- Last posted
- Jul 9, 2021
- Enrollment
- 1200
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- D'Or Institute for Research and EducationLead sponsor
- Butantan InstituteCollaborator
- D'Or Institute for Research and EducationReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.